deltatrials
Completed OBSERVATIONAL NCT02052895

Utility of Presepsin in Distinguishing Between Sepsis and SIRS

Utility of Presepsin in Distinguishing Between Sepsis and SIRS (Systemic Inflammatory Response Syndrome): an Exploratory, Prospective Observational Study in Critically Ill Patients

Sponsor: Mochida Pharmaceutical Company, Ltd.

Conditions SIRS Sepsis
Updated 13 times since 2017 Last updated: Aug 19, 2018 Started: Jan 31, 2014 Primary completion: Jul 31, 2015 Completion: Jul 31, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on SIRS and Sepsis, this trial is completed. The trial is conducted by Mochida Pharmaceutical Company, Ltd. and has accumulated 13 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Aug 2017 · 7 months · monthly snapshot~Aug 2017 – ~Apr 2018 · 8 months · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshot~Sep 2018 – ~Nov 2020 · 26 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Dec 2022 · 12 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

13 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2023 — Jul 2024 [monthly]

    Completed

  4. Dec 2022 — Jan 2023 [monthly]

    Completed

  5. Dec 2021 — Dec 2022 [monthly]

    Completed

▶ Show 8 earlier versions

  1. Jan 2021 — Dec 2021 [monthly]

    Completed

  2. Nov 2020 — Jan 2021 [monthly]

    Completed

  3. Sep 2018 — Nov 2020 [monthly]

    Completed

  4. Jun 2018 — Sep 2018 [monthly]

    Completed

  5. May 2018 — Jun 2018 [monthly]

    Completed

  6. Apr 2018 — May 2018 [monthly]

    Completed

    Phase: NA → None

  7. Aug 2017 — Apr 2018 [monthly]

    Completed NA

  8. Jan 2017 — Aug 2017 [monthly]

    Completed NA

    First recorded

Jan 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Mochida Pharmaceutical Company, Ltd.
Data source: Mochida Pharmaceutical Company, Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations